[Federal Register Volume 64, Number 200 (Monday, October 18, 1999)]
[Notices]
[Pages 56227-56228]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-27096]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated March 3, 1999, and published in the Federal
Register on April 1, 1999, (64 FR 15810), Roxane Laboratories, Inc.,
1809 Wilson Road, P.O. Box 16532, Columbus, Ohio 43216-6532, made
application by renewal to the Drug Enforcement Administration to be
registered as an
[[Page 56228]]
importer of cocaine (9041), a basic class of controlled substance
listed in Schedule II.
The firm plans to import cocaine to manufacture topical solutions
for distribution to customers.
A registered bulk manufacturer of cocaine filed written comments
and an objection in response to the Notice of Application. The objector
argues that it would not be in the public interest to register Roxane
because it would violate United States policy against the use of seized
material and that competition is adequate. Both of these issues have
already been considered and addressed in Roxane's Notice of
Registration published in the Federal Register on October 19, 1998 (63
FR 5589).
DEA has considered the factors in Title 21, Untied States Code,
Section 823(a) and 952(a) and determined that the registration of
Roxane Laboratories, Inc. to import cocaine is consistent with the
public interest and with United States obligations under international
treaties, conventions, or protocols in effect on May 1, 1971, at this
time. DEA has investigated Roxane Laboratories, Inc. on a regular basis
to ensure that the company's continued registration is consistent with
the public interest. These investigations have included inspection and
testing of the company's physical security systems, audits of the
company's records, verification of the company's compliance with state
and local laws, and a review of the company's background and history.
Therefore, pursuant to Section 1008(a) of the Controlled Substances
Import and Export Act and in accordance with Title 21, Code of Federal
Regulations, Section 1301.34, the above firm is granted registration as
an importer of the basic class of controlled substance listed above.
Dated: October 8, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control Drug
Enforcement Administration.
[FR Doc. 99-27096 Filed 10-15-99; 8:45 am]
BILLING CODE 4410-09-M